多糖疫苗

5～60岁人群伤寒Vi多糖疫苗和A群脑膜炎球菌多糖疫苗大规模接种结果分析

Analysis on the Result of the Mass Vaccination Campaign of Typhoid Vi Polysaccharide Vaccine and Meningococcal A Polysaccharide Vaccine Targeted 5-60 Years Old Population

结论A+C疫苗和伤寒Vi多糖疫苗一样，接种反应轻微，安全性好；

Conclusion The injection reaction of A + C meningococcal polysaccharide vaccine as well as that of typhoid Vi polysaccharide vaccine is mild and safety .

对于B群，不能开发出多糖疫苗，因其与人体神经组织中的多糖存在抗原模拟。

For group B , polysaccharide vaccines cannot be developed , due to antigenic mimicry with polysaccharide in human neurologic tissues .

伤寒Vi多糖疫苗的研究和应用

Study and Application on Salmonella Typhi Vi Capsular Polysaccharide Vaccine

伤寒Vi多糖疫苗主要用于5岁以上人群预防伤寒，目前我国已取得正式生产文号。

The Vi polysaccharide of Typhoid is a licensed vaccine for Typhoid Fever in individuals ≥ 5 years old in China .

Hib疫苗主要有荚膜多糖疫苗和荚膜多糖-蛋白质结合疫苗。

Hib vaccines include capsular polysaccharide vaccines and capsular polysaccharide-protein conjugate vaccines .

目的研制A、C、W135、Y群脑膜炎球菌四价多糖疫苗，并采用新方法去除细菌内毒素。

Objective To prepare meningococcal polysaccharide vaccine groups A , C , W135 and Y and remove bacterial endotoxin by a novel method .

除了灭活疫苗、减毒疫苗、结合多糖疫苗和亚单位疫苗外，新近出现的DNA疫苗、转基因植物疫苗和ghost疫苗技术为疫苗的研制提供了新的思路。

It is important to explore an effective vaccine against it . With the development of vaccine strategy and technology , some new vaccines are being developed , such as DNA vaccine , transgenic plant vaccine , and ghost vaccine .

肺炎球菌多糖疫苗在两组中同样有效。

The pneumococcal polysaccharide vaccine was equally effective in both groups .

23价肺炎球菌多糖疫苗预防老年人下呼吸道感染的效果考察

Effectiveness of 23-valent Pneumococcal Polysaccharide Vaccine to Prevent LRTIs in the Elderly Population

支气管扩张病例应用23价肺炎球菌多糖疫苗的临床观察

Clinical observation on the application of 23-valent pneumococcus polysaccharide vaccine in bronchiectatic patients

A+C群脑膜炎球菌多糖疫苗大规模接种后的速发型接种反应观察

Immediate Adverse Reaction after Mass Vaccination of Groups A + C Meningococcal Polysaccharide Vaccine

培养时间对A群脑膜炎球菌多糖疫苗质量的影响

The Influence of Culture Time on Quality of Polysaccharide Vaccine of Meningococcal Group A

冻干伤寒Vi+A群流脑二联多糖疫苗的研究

Study on freeze-dried bivalent polysaccharide combined vaccine of Typhoid Vi and Meningococcus group A

冻干A+C群脑膜炎球菌多糖疫苗安全性和免疫原性观察

Observation on the safety and immunogenicity of group A + C meningococcal polysaccharide vaccine

23价肺炎链球菌荚膜多糖疫苗的研制

Preparation of 23-valent Pneumococcal Capsular Polysaccharide Vaccine

目的：探讨23价肺炎球菌多糖疫苗在支气管扩张患者的临床意义。

Objective : To investigate clinical significance in the application of 23-valent pneumococcus polysaccharide vaccine in bronchiectatic patients .

A+C群脑膜炎球菌多糖疫苗的制备及其接种人体后的血清学效果

Preparation of group A + C Meningococcal polysaccharide vaccine and analysis of the efficacy in the vaccinated human antiserum

肺炎球菌多糖疫苗对老龄大鼠肺组织-防御素-2表达的影响

Study of β - defensin-2 Gene Expression in the Pulmonary Tissue of the Older Rat Stimulated by Pneumococcal Vaccine Polyvalent

战略还要求确保具备足够数量的现有可得脑膜炎球菌多糖疫苗用于应对疫情。

It also requires ensuring that adequate quantities of the currently available meningococcal polysaccharide vaccines are available for epidemic response .

为确定A+C群脑膜炎球菌多糖疫苗有效期，对该疫苗在不同储藏温度下的稳定性进行了系统研究。

In order to finalize the expiry date , the stability of group A + C Meningococcal polysaccharide vaccine in different of storage temperature was studied .

此外，为迅速处理潜在疫苗供应的短缺，世卫组织决定评估全世界多糖疫苗生产企业的状况和生产能力。

Furthermore , to rapidly address the potential shortage of vaccine supply , WHO decided to assess the status and production capacity of polysaccharide manufactures worldwide .

在这个研究中，340名孕妇在孕期第三个三个月中被随机的分配接受灭活流感疫苗或者23-价肺炎球菌多糖疫苗注射（对照）。

In this study , 340 pregnant women in the third trimester were randomly assigned to receive inactivated influenza vaccine or the23-valent pneumococcal polysaccharide vaccine ( control ) .

结论：23价肺炎球菌多糖疫苗能有效地减少支气管扩张患者肺部感染复发率，是临床佐治支气管扩张患者的一个有效方法，值得临床推广。

Conclusion : 23-valent pneumococcus polysaccharide vaccine could effectively reduce recurrent rate of pulmonary infection in bronchiectatic patients . Therefore , it might be an effective adjuvant for the treatment of bronchiectasis , which is worth extending its clinical application .

滇西北亚高山4种乡土阔叶树种1年生容器苗的育苗容器规格及基质研究A+C群脑膜炎球菌多糖疫苗大规模接种后的速发型接种反应观察

The Effect of different Sizes of Container and Media for One Year Old Seedlings of Four Types of Aboriginal Broadleaf in Subalpine Area in Northwest Yunnan Immediate Adverse Reaction after Mass Vaccination of Groups A + C Meningococcal Polysaccharide Vaccine

C群脑膜炎球菌荚膜多糖结合疫苗的研制

Preparation of group C meningococcal polysaccharide conjugate vaccine

缓释伤寒荚膜多糖微球疫苗免疫动物的实验研究

Experimental Study of Controlled Release Microencapsulated Samonella Typhi Capsular Polysaccharide Vaccines Immunized Mice

目的制备安全、效的A群脑膜炎球菌多糖结合疫苗。

Objective To prepare safe and valid Group A Meningococcal polysaccharide conjugate vaccine .

b型流感嗜血杆菌多糖结合疫苗的研制

Preparation of Hemophilus Influenza B Polysaccharide Conjugated Vaccine

结论已成功研制出冻干A+C群脑膜炎球菌多糖结合疫苗，该制备工艺是可行的。

Conclusion Freeze-dried A + C meningococcal polysaccharide conjugate vaccine was successfully prepared , and the production procedure was feasible .